Your session is about to expire
← Back to Search
WAVE-TW Arm for Post-Traumatic Stress Disorder (WAVE-TW Trial)
WAVE-TW Trial Summary
This trial aims to find an effective intervention for treating PTSD and depression in transgender women living with HIV, which will hopefully lead to improved ART adherence and viral suppression.
- Post-Traumatic Stress Disorder
- Depression
- HIV/AIDS
WAVE-TW Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowWAVE-TW Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.WAVE-TW Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are recruited for this clinical undertaking?
"Indeed, the information on clinicaltrials.gov demonstrate that this study is presently enrolling individuals. It was initially posted on October 22nd 2020 and last modified on May 23rd 2022 in order to enlist 20 patients from a single site."
Are there current openings for people to take part in this medical experiment?
"According to information on clinicaltrials.gov, this medical trial is currently open for recruitment which began when it was first posted on October 22nd of 2020 and continued up until its most recent update on May 23rd 2022."
What are the desired results projected from this research endeavor?
"This clinical trial's primary outcome, measured over an 11 month period, is the number of visits completed. The secondary outcomes will include changes in depressive symptoms as assessed by the CES-D Scale, viral load suppression and PTSD symptom change as evaluated with a DSM-5 Checklist; all providing insight into potential benefits stemming from this intervention."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger